Dr. Cheryl McDonald, M.D.
What this data tells you about Dr. McDonald
Dr. Cheryl McDonald is an infectious disease in Fort Worth, TX, with 20 years in practice. Based on federal Medicare data, Dr. McDonald performed 34,794 Medicare services across 1,129 unique beneficiaries.
Between the years covered by Open Payments, Dr. McDonald received a total of $193,915 from 36 pharmaceutical and/or device companies across 717 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McDonald is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Immune globulin infusion (Gammagard) | 14,940 | $36 | $298 |
| Injection, dalbavancin, 5 mg | 12,300 | $12 | $43 |
| Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg | 4,370 | $52 | $252 |
| Hospital follow-up visit, moderate complexity | 727 | $62 | $250 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 578 | $16 | $50 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 570 | $50 | $158 |
| Hospital follow-up visit, high complexity | 430 | $93 | $227 |
| Office visit, established patient (30-39 min) | 288 | $93 | $225 |
| Initial hospital admission, moderate complexity | 134 | $101 | $297 |
| Injection of additional new drug or substance into vein | 122 | $12 | $55 |
| Office visit, established patient (20-29 min) | 115 | $61 | $148 |
| Initial hospital admission, high complexity | 94 | $137 | $434 |
| New patient office visit (45-59 min) | 42 | $127 | $349 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 32 | $18 | $54 |
| Collection of blood sample from central venous tube | 28 | $23 | $55 |
| Hospital follow-up visit, low complexity | 24 | $39 | $89 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in infectious disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for infectious disease in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. McDonald is a mixed practice specialist, with above-average Medicare volume (top 4% in TX), and high industry engagement (speaking/promotional, top 3%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. McDonald experienced with immune globulin infusion (gammagard)?
Does Dr. McDonald receive payments from pharmaceutical companies?
How do Dr. McDonald's costs compare to other infectious diseases in Fort Worth?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology